Human Anti-VP6 Recombinant Antibody (clone 6-26)
CAT#: PABL-323
Recombinant Human Antibody ('6-26) is capable of binding to RV VP6, expressed in HEK 293 cells. Expressed as the combination of a heavy chain (HC) containing VH from anti-RV VP6 mAb and CH1-3 region of human IgG1 and a light chain (LC) encoding VL from anti-RV VP6 mAb and CL of human kappa light chain. Exists as a disulfide linked dimer of the HC and LC hetero-dimer under non-reducing condition.
Published Data
Figure 1 The equilibrium binding affinity of the wild-type or mutant Fabs determined by ELISA binding to viral double-layered particles.
Kallewaard, N. L., McKinney, B. A., Gu, Y., Chen, A., Prasad, B. V., & Crowe, J. E. (2008). Functional maturation of the human antibody response to rotavirus. The Journal of Immunology, 180(6), 3980-3989.
Figure 2 Representative surface plasmon resonance binding curves showing the interaction between VP6 and the mutant RV-specific Fabs that were decreased in overall affinity in comparison to the wild-type Fab. Binding curves of RV6-26 wild-type and mutants at a concentration of 12.5 nM.
Kallewaard, N. L., McKinney, B. A., Gu, Y., Chen, A., Prasad, B. V., & Crowe, J. E. (2008). Functional maturation of the human antibody response to rotavirus. The Journal of Immunology, 180(6), 3980-3989.
Figure 3 RRV DLP were coated on microplates and differing concentrations of Fab, IgG or IgA forms of RV6-26 or 2D1 control human antibody (specific for the HA protein of 1918 influenza) normalized for binding sites (Fab = 1; IgG = 2 and IgA = 4) were allowed to bind to DLP. Bound antibodies were detected using peroxidase-conjugated anti-human κ chain antibodies, and the absorbance values are shown.
Aiyegbo, M. S., Sapparapu, G., Spiller, B. W., Eli, I. M., Williams, D. R., Kim, R.,... & Nannemann, D. P. (2013). Human rotavirus VP6-specific antibodies mediate intracellular neutralization by binding to a quaternary structure in the transcriptional pore. PloS one, 8(5), e61101.
Figure 4 Anti-rotaviral activity of RV6-26.
(A) Inhibition of in vitro transcription: EDTA-activated DLP were incubated with 200 nM combining sites of different antibodies and mRNA was synthesized in vitro using selected components of the Riboprobe SP6 system (transcription was mediated by the viral RNA-dependent RNA polymerase not the SP6 DNA-dependent RNA polymerase). First-strand cDNA was synthesized by reverse transcription using a VP6-specific primer. Amplification of cDNA with VP6-specific primers was monitored in a real-time PCR using SYBR Green; the concentrations of RNA estimated from a standard curve constructed using reference RNA extracted from RRV are plotted. (B) Inhibition of rotavirus replication by IgA: polarized monolayers of Caco-2 cells grown on Transwell inserts were treated with polymeric IgA in the basal compartment and inoculated apically with trypsin-activated RRV (MOI = 5) at ambient temperature for 1 h and then cultured for 16 in medium containing trypsin. Amount of rotavirus in the inserts was titrated by inoculating MA104 cells and culturing for 16 h, followed by acetone-fixation and staining with anti-rotavirus polyclonal antibodies conjugated to either Alexa568 or IRDye 800. Detection was done either by scanning on Licor or by counting fluorescent foci.
Aiyegbo, M. S., Sapparapu, G., Spiller, B. W., Eli, I. M., Williams, D. R., Kim, R.,... & Nannemann, D. P. (2013). Human rotavirus VP6-specific antibodies mediate intracellular neutralization by binding to a quaternary structure in the transcriptional pore. PloS one, 8(5), e61101.
❮
❯
Specifications
- Immunogen
- Human Capsid protein VP6
- Host Species
- Human
- Type
- Human IgG
- Specificity
- Human VP6
- Species Reactivity
- Human
- Clone
- 6-26
- Applications
- Neut, FuncS
Product Property
- Purity
- >95% as determined by SDS-PAGE and HPLC analysis
- Concentration
- Please refer to the vial label for the specific concentration.
- Storage
- Centrifuge briefly prior to opening vial. Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
Applications
- Application Notes
- The antibody was validated for ELISA and Inhibition. For details, refer to Published Data.
Target
- Alternative Names
- Capsid protein VP6; capsid protein VP6; protein VP6; VP6
REVIEWS AND Q&AS
CITATIONS
RESOURCES
DOWNLOADS
RELATED PRODUCTS
Inquiry
Navs
Customer Review
There are currently no Customer reviews or questions for PABL-323. Click the button above to contact us or submit your feedback about this product.
Submit Your Publication
Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.
Downloadable Resources
Download resources about recombinant antibody development and antibody engineering to boost your research.
Product Notes
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Datasheet
MSDS
COA
Certificate of Analysis LookupTo download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number:
See other products for "Clone 6-26"
- CAT
- Product Name
See other products for "VP6"
Select a product category from the dropdown menu below to view related products.
| CAT | Product Name | Application | Type |
|---|---|---|---|
| MOB-1043 | Recombinant Anti-VP6 Antibody | WB, Neut, FuncS | IgG |
| MHH-1043 | Recombinant Human Anti-VP6 Antibody | ELISA, WB, FuncS | IgG |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| MOB-1043-F(E) | Recombinant Anti-VP6 Antibody Fab Fragment | WB, IP, FuncS | Fab |
| MHH-1043-F(E) | Recombinant Human Anti-VP6 Antibody Fab Fragment | ELISA, IP, FuncS | Fab |
| PFBL-323 | Human Anti-VP6 Recombinant Antibody (clone 6-26); Fab Fragment | Neut, FuncS | Human Fab |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| MOB-1043-S(P) | Recombinant Anti-VP6 Antibody scFv Fragment | ELISA, WB, IF, FuncS | scFv |
| MHH-1043-S(P) | Recombinant Human Anti-VP6 Antibody scFv Fragment | ELISA, WB, FuncS | scFv |
| PSBL-323 | Human Anti-VP6 Recombinant Antibody (clone 6-26); scFv Fragment | Neut, FuncS | Human scFv |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| HPAB-1457-FY | Llama Anti-VP6 Recombinant Antibody (HPAB-1457-FY) | WB, ELISA | Llama VHH |
| HPAB-1458-FY | Llama Anti-VP6 Recombinant Antibody (HPAB-1458-FY) | WB, ELISA | Llama VHH |
| HPAB-1459-FY | Llama Anti-VP6 Recombinant Antibody (HPAB-1459-FY) | WB, ELISA, Neut | Llama VHH |
| HPAB-1460-FY | Llama Anti-VP6 Recombinant Antibody (HPAB-1460-FY) | WB, ELISA, Neut | Llama VHH |
Specific Inquiry
Add to compare
See Our Custom Production in Action
Popular Products
Application: ELISA, IP, FC, FuncS, Neut, IF, ICC
Application: ELISA, Neut, IF, IP, FC, FuncS
Application: FC, IP, ELISA, Neut, FuncS, IF, WB
Application: IP, IF, FuncS, FC, Neut, ELISA, ICC
Application: WB, ELISA, FC, IP, FuncS, IF, Neut
Application: IF, IP, Neut, FuncS, ELISA, FC, ICC
Application: ELISA, IHC, FC, IP, IF, BL
Application: ELISA, IHC, FC, IP, IF, Inhib
Application: ELISA, Neut
Application: ELISA, Neut
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
